Valuation Haemonetics Corporation
Stocks
HAE
US4050241003
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
16:00:02 2026-10-12 EDT
|
5-day change | 1st Jan Change | ||
| 122.06 USD | +2.84% |
|
+16.60% | +52.29% |
| 10-09 | Barrington Adjusts Price Target on Haemonetics to $140 From $118, Keeps Outperform Rating | MT |
| 10-08 | CSL to Transition US Plasma Centers to Haemonetics' Latest Plasmapheresis Platform | MT |
Company Valuation: Haemonetics Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,068 | 3,992 | 4,335 | 3,175 | 2,511 | 5,553 | - | - |
| Change | - | 30.13% | 8.58% | -26.76% | -20.89% | 121.13% | - | - |
| Enterprise Value (EV) 1 | 3,582 | 4,473 | 4,335 | 4,093 | 3,490 | 6,215 | 5,880 | 5,522 |
| Change | - | 24.89% | -3.1% | -5.58% | -14.71% | 78.07% | -5.39% | -6.1% |
| P/E | 71.5x | 35.3x | 37.3x | 19.1x | 26.4x | 30.7x | 26.7x | 22x |
| PBR | 4.09x | 4.88x | - | 3.71x | 3.21x | 5.22x | 4.07x | 3.28x |
| PEG | - | 0x | 16.71x | 0.4x | -0.7x | 0.3x | 1.7x | 1.1x |
| Capitalization / Revenue | 3.09x | 3.42x | 3.31x | 2.33x | 1.88x | 3.92x | 3.7x | 3.43x |
| EV / Revenue | 3.61x | 3.83x | 3.31x | 3.01x | 2.62x | 4.38x | 3.92x | 3.41x |
| EV / EBITDA | 12.6x | 14.7x | 11.7x | 9.67x | 7.93x | 13.7x | 12x | 9.76x |
| EV / EBIT | 19.1x | 20.5x | 15.7x | 12.5x | 10.3x | 16.9x | 14.6x | 12.3x |
| EV / FCF | - | - | 37.5x | 33.7x | 13.4x | 19.6x | 17.6x | 15.4x |
| FCF Yield | - | - | 2.66% | 2.96% | 7.46% | 5.1% | 5.7% | 6.48% |
| Dividend per Share 2 | - | - | - | - | - | 1 | - | - |
| Rate of return | - | - | - | - | - | 0.82% | - | - |
| EPS 2 | 0.84 | 2.24 | 2.29 | 3.31 | 2.05 | 3.97 | 4.58 | 5.537 |
| Distribution rate | - | - | - | - | - | 25.2% | - | - |
| Net sales 1 | 993.2 | 1,169 | 1,309 | 1,361 | 1,334 | 1,418 | 1,501 | 1,618 |
| EBITDA 1 | 284.9 | 304.7 | 370.1 | 423.3 | 440.1 | 452.5 | 491.8 | 565.6 |
| EBIT 1 | 187.1 | 218.4 | 276.5 | 326.3 | 338.5 | 368.5 | 401.7 | 449.2 |
| Net income 1 | 43.38 | 115.4 | 117.6 | 167.7 | 97.31 | 177.9 | 212.4 | 254.8 |
| Net Debt 1 | 514.1 | 481.4 | - | 918 | 979.1 | 662 | 327.1 | -31.34 |
| Reference price 2 | 60.02 | 79.13 | 85.35 | 63.19 | 54.04 | 122.06 | 122.06 | 122.06 |
| Nbr of stocks (in thousands) | 51,112 | 50,448 | 50,786 | 50,237 | 46,471 | 45,497 | - | - |
| Announcement Date | 5/10/22 | 5/11/23 | 5/9/24 | 5/8/25 | 5/7/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.9x | 4.28x | 13.4x | 0.84% | 5.4B | |
| 29.16x | 3.91x | 15.12x | 2.58% | 172B | |
| 18.92x | 3.45x | 12.33x | 3.18% | 113B | |
| 21.59x | 4.25x | 14.82x | 1.3% | 106B | |
| 25.92x | 2.55x | 10.24x | 2.77% | 75.31B | |
| 17.73x | 0.21x | 12.94x | 0.73% | 61.8B | |
| 30.68x | 7.58x | 19.64x | 1.3% | 52.93B | |
| 35.41x | 3.42x | 11.72x | 2.14% | 50.05B | |
| 35.08x | 8.72x | 24.53x | -.--% | 40.81B | |
| 48.93x | 1.34x | 12.38x | 0.2% | 31.81B | |
| Average | 29.33x | 3.97x | 14.71x | 1.5% | 71B | |
| Weighted average by Cap. | 26.84x | 3.82x | 14.43x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HAE Stock
- Valuation Haemonetics Corporation
Select your edition
All financial news and data tailored to specific country editions
